March 30th 2023
Multiple studies have indicated a greater risk of neonatal morbidity and mortality when births occur in out-of-hospital settings.
Aspirin discontinuation in pregnancies at high risk for preterm preeclampsiaMarch 3rd 2023
For pregnant women at high risk of preeclampsia, aspirin discontinuation at 24 to 28 weeks’ gestation was comparable to aspirin continuation for preventing preterm preeclampsia, according to recent clinical trial data.
Safety of cefazolin has been underestimated for GBS prophylaxis during laborFebruary 20th 2023
Both undertreatment and overtreatment were common in this cohort of penicillin-allergic pregnant women with Group B Streptococcus (GBS).
Clinician perspectives on migraine control during pregnancyFebruary 20th 2023
Brian Grosberg, MD, and Stephanie Bakaysa, MD, of Hartford HealthCare Medical Group, offered their clinical perspectives on the recently published survey study on management for migraines during pregnancy.
Study details causal relationship between hypertensive disorders of pregnancy and future cardiovascular riskFebruary 20th 2023
A genome-wide genetic association study using mendelian randomization provides insight into the causal relationships between HDPs and coronary artery disease and ischemic stroke later in life.
Large, real-world study finds Jada System safe, effective for postpartum hemorrhageFebruary 11th 2023
In the study, investigators analyzed the Jada System in 800 patients from October 2020 to April 2022 across 16 hospitals in the United States. Results of the study were presented at the SMFM 43rd Annual Pregnancy Meeting in San Francisco, California.
Azithromycin reduces risk of maternal sepsis, death in vaginal deliveryFebruary 10th 2023
A single oral dose of azithromycin in women in labor planning vaginal delivery significantly reduced the risk of maternal death and sepsis, according to study results presented at the SMFM 43rd Annual Pregnancy Meeting.
Knowledge and comfort in treating migraine during pregnancyFebruary 10th 2023
The clinical psychologist from Ayer Neuroscience Institute at Hartford Healthcare Headache Center shared some highlights from her recently published survey study on migraine treatment during pregnancy.
Survey: Varied levels of comfort for migraine treatment during pregnancyFebruary 3rd 2023
Majority of women’s health care providers reported in a survey feeling either somewhat or very comfortable with recommending or continuing acute treatments for pregnant patients with migraine.
Preeclampsia increases heart attack, stroke risk for up to 20 years after pregnancyJanuary 31st 2023
An analysis of registry data recorded in Denmark over a 4-decade period offers an overview of the risk of acute myocardial infarction and ischemic stroke incurred as a result of preeclampsia during pregnancy and how this risk changes over time.
FDA advisory panel votes to withdraw approval of premature birth prevention drugOctober 19th 2022
An advisory panel for the US Food and Drug Administration voted 14-1 to withdraw 17α-hydroxyprogesterone caproate (Makena; Covis Pharma) from the market.
Researchers investigate psoriasis and adverse pregnancy outcomesJuly 14th 2022
A study published in JAAD International examined the association between psoriasis and adverse pregnancy outcomes (APOs) and found that providers should be on the lookout for ectopic pregnancies (EP) in this population.
Hypertension disorders of pregnancy linked to worsened risk of chronic hypertension later in lifeJuly 6th 2022
Gregory Weiss, MD, provides perspective on a recent study suggesting women with gestational hypertension were at an increased risk of chronic hypertension later in life.